The novel Akt inhibitor AZD5363 following radiotherapy improves tumor control in mouse models of head and neck cancer

Emma Searle, Brian Telfer, Duncan Forster, Barry R. Davies, Ian Stratford, Timothy Illidge, Kaye Williams

Research output: Contribution to journal › Meeting Abstract › peer-review

Research Beacons, Institutes and Platforms

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{9c9f3d48db4747519487e0aeaa279bb9,

title = "The novel Akt inhibitor AZD5363 following radiotherapy improves tumor control in mouse models of head and neck cancer",

author = "Emma Searle and Brian Telfer and Duncan Forster and Davies, {Barry R.} and Ian Stratford and Timothy Illidge and Kaye Williams",

year = "2016",

month = jul,

day = "22",

doi = "10.1158/1538-7445.AM2016-3042",

language = "English",

volume = "76",

pages = "3042",

journal = "Cancer Research",

issn = "0008-5472",

publisher = "American Association for Cancer Research",

number = "14",

}

TY - JOUR

T1 - The novel Akt inhibitor AZD5363 following radiotherapy improves tumor control in mouse models of head and neck cancer

AU - Searle, Emma

AU - Telfer, Brian

AU - Forster, Duncan

AU - Davies, Barry R.

AU - Stratford, Ian

AU - Illidge, Timothy

AU - Williams, Kaye

PY - 2016/7/22

Y1 - 2016/7/22

U2 - 10.1158/1538-7445.AM2016-3042

DO - 10.1158/1538-7445.AM2016-3042

M3 - Meeting Abstract

SN - 0008-5472

VL - 76

SP - 3042

JO - Cancer Research

JF - Cancer Research

IS - 14

ER -